Vilatin DP 10/100 Tablets SR
₹155
₹210
₹155
₹210
Vilatin
Vilatin DP 10/100 Tablets SR
Net Qty: 10 Tablet
₹155
26% Off
MRP₹210(incl. of all taxes)
Prescription required
Coupons & Offers
No Return or Exchange
Fast Delivery
Highlights
composition with strength
Dapagliflozin(10Mg), Vildagliptin(100Mg)
description
Controls high blood glucose levels, helps reduce cardiovascular risk, supports insulin utilization, aids in diabetes management, suitable for type-2 diabetes management
key benefits
Treatment of Type 2 diabetes mellitus
side effects
Nausea , Nasopharyngitis (inflammation of the throat and nasal passages) , Urinary tract infection , Polyuria , Increased appetite , Vomiting and Constipation
how to use
Take this medication as prescribed by your doctor. Swallow it whole—do not chew, crush, or break it.
lactation interaction
Consult Your Doctor
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship. While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited, Unit 803, Lodha Supremus, Saki Vihar Road, Opp MTNL, Office, Powai, Mumbai, Maharashtra, India,400072 For Support ReachOut : support+geddit@zeptonow.com
Seller License No.
11521998000248
Country of Origin
India
Manufacturer Name
Ajanta Pharma Limited
Shelf Life
24 months
Expires on or after
February 2026